Amoroso, Jennifer I.
HRN: 18-44-05 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/20/2022
CEFUROXIME 1.5GM (VIAL)
09/20/2022
09/20/2022
IVTT
1.5gm
LD
Stat CS
Waiting Final Action
09/22/2022
CEFUROXIME 500MG (TAB)
09/22/2022
09/29/2022
ORAL
500mg
BID
Post CS
Waiting Final Action